Postoperative ctDNA Provides Prognostic Value for DFS Outcomes in CRC
Circulating tumor DNA status at the time of postoperative minimal residual disease assessment was found to be a prognostic factor for disease-free survival in patients with radically resected stage II to IV colorectal cancer.
Source: onclive.com